Muun Health OU

Muun Health OU, based in Estonia, develops an innovative wearable device that facilitates real-time monitoring of female hormones, enhancing women’s hormonal well-being and addressing infertility issues. Founded in 2023 in Parnu, Estonia, Muun Health OU specializes in female hormonal health solutions. The company has secured EUR 545,000 in funding from Greiner Innoventures and The Better Fund in its recent round, aimed at further developing its products. Muun Health has completed one funding deal to date, with the latest transaction occurring on November 6, 2025.

The founder's history is not disclosed, nor are there mentions of any subsidiaries or past companies. Muun Health specializes in a wearable device that continuously monitors key female sex hormones throughout the day, providing insights through a dedicated mobile application. This technology is tailored for women seeking a better understanding of their reproductive health, particularly for those facing infertility challenges. The product is designed to help users identify their conception windows, with the primary market being women across North America and Europe.

Muun Health's revenue model focuses on direct-to-consumer subscriptions for access to hormonal monitoring technology. Customers engage through a streamlined process that facilitates subscription renewals and updates. While specific pricing is not disclosed, the model ensures a consistent income stream through recurring transactions, fostering long-term user relationships. In November 2025, Muun Health OU raised EUR 545,000 in pre-seed funding from Greiner Innoventures and The Better Fund.

This funding will be utilized to enhance the development of its wearable hormone monitoring device, secure intellectual property rights, and support clinical testing initiatives. The company is targeting further expansion into new markets, particularly in North America and Europe, to meet the growing demand for personalized health solutions.